NanoViricides, Inc.
NNVC · AMEX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $21,164 | $21,961 | $13,370 | $21,685 |
| - Cash | $1,559 | $4,798 | $8,150 | $14,066 |
| + Debt | $0 | $0 | $0 | $95 |
| Enterprise Value | $19,605 | $17,164 | $5,220 | $7,714 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,723 | -$7,485 | -$7,840 | -$7,378 |
| % Margin | – | – | – | – |
| Net Income | -$9,467 | -$8,294 | -$8,589 | -$8,107 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.63 | -0.7 | -0.74 | -0.7 |
| % Growth | 10% | 5.4% | -5.7% | – |
| Operating Cash Flow | -$8,479 | -$6,316 | -$5,670 | -$5,891 |
| Capital Expenditures | -$57 | -$157 | -$152 | -$324 |
| Free Cash Flow | -$8,536 | -$6,472 | -$5,822 | -$6,216 |